- $131.09m
- $375.25m
- $452.87m
- 79
- 93
- 22
- 70
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 506 | 583 | 538 | 405 | 453 |
Cost of Revenue | |||||
Gross Profit | 503 | 579 | 536 | 404 | 451 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 425 | 529 | 664 | 508 | 482 |
Operating Profit | 81.4 | 53.3 | -126 | -103 | -29.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 83.5 | 54 | -125 | -106 | -30.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 66.9 | 45.5 | -104 | -88.7 | -28.2 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 66.9 | 45.5 | -104 | -88.7 | -28.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 66.9 | 45.5 | -123 | -119 | -66.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.73 | 1.68 | -3.35 | -3.9 | -2.37 |